Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Anebulo Pharmaceuticals, Inc. (ANEB)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-22Jun-30-21Jun-30-20
   10-K10-K8-K
Research and development  3.02.3 
General and administrative  3.91.30.0
    Total operating expenses  6.83.60.2
    Loss from operations  -6.8-3.6-0.2
Other income, net  0.00.0 
    Net loss  -6.8-30.3-0.2
   
Weighted average common shares outstanding, basic and diluted  23.313.612.0
   
Net loss per share, basic and diluted  ($0.29)($2.83)($0.01)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy